Woodline-Partners-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
891
Total Value
15376793692
Accession Number
0001172661-25-002043
Form Type
13F-HR
Manager Name
Woodline-Partners-Lp
Data Enrichment
97% identified
867 identified24 unidentified

Holdings

891 positions • $15.4B total value
Manager:
Search and click to pin securities to the top
Page 45 of 45
Kalaris Therapeutics, Inc.
Shares:21.5K
Value:$172.8K
% of Portfolio:0.0% ($172.8K/$15.4B)
Intellia Therapeutics, Inc.
Shares:24.1K
Value:$171.4K
% of Portfolio:0.0% ($171.4K/$15.4B)
Mersana Therapeutics, Inc.
Shares:435.6K
Value:$149.9K
% of Portfolio:0.0% ($149.9K/$15.4B)
Third Harmonic Bio, Inc.
Shares:40.7K
Value:$141.2K
% of Portfolio:0.0% ($141.2K/$15.4B)
Kezar Life Sciences, Inc.
Shares:25.6K
Value:$124.7K
% of Portfolio:0.0% ($124.7K/$15.4B)
BioAge Labs, Inc.
Shares:31.6K
Value:$118.7K
% of Portfolio:0.0% ($118.7K/$15.4B)
Caribou Biosciences, Inc.
Shares:122.1K
Value:$111.5K
% of Portfolio:0.0% ($111.5K/$15.4B)
IGM Biosciences, Inc.
Shares:69.6K
Value:$80.0K
% of Portfolio:0.0% ($80.0K/$15.4B)
BioAtla, Inc.
Shares:76.3K
Value:$26.5K
% of Portfolio:0.0% ($26.5K/$15.4B)
Neumora Therapeutics, Inc.
Shares:15.0K
Value:$15.0K
% of Portfolio:0.0% ($15.0K/$15.4B)
SANGAMO THERAPEUTICS, INC
Shares:19.2K
Value:$12.6K
% of Portfolio:0.0% ($12.6K/$15.4B)